Barclays’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-18,000
Closed -$562K 6344
2019
Q4
$562K Buy
+18,000
New +$515K ﹤0.01% 4197
2019
Q3
Sell
-161,400
Closed -$9.61M 6969
2019
Q2
$9.61M Buy
161,400
+108,700
+206% +$6.23M 0.01% 1380
2019
Q1
$3.26M Buy
+52,700
New +$2.99M ﹤0.01% 2056

Other funds holding MMSI

Barclays's MMSI Position: Q2 2026 in Review

Barclays increased its Merit Medical Systems (MMSI) stake by 17% in Q2 2026, buying an estimated $702K and bringing the position to 71,908 shares worth $4.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

Barclays first reported a position in MMSI in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.7M in Q1 2025. 405 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Barclays held 71,908 shares of Merit Medical Systems worth $4.99M as of Q2 2026.
  • Barclays bought 10,648 Merit Medical Systems shares in Q2 2026, an estimated $702K.
  • Merit Medical Systems made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1847 holding.
  • Barclays first reported a position in Merit Medical Systems in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Merit Medical Systems position peaked at $13.7M in Q1 2025.
  • 405 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.